Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ATYR

Atyr Pharma Inc

Jun 09 • 04:00PM ET

0.4556

+0.0135 3.05 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: ANIX LONA NRXS COYA CYPH INO KALA CGTX KLRS NRXP

| Held by: VTI IWM VXF VTWO IWO IWC VTWG ITOT RSSL IWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.73	Insider Own	2.59%	Shs Outstand	98.05M	Perf Week	-12.38%
Market Cap	44.67M	Forward P/E	-	EPS next Y	-0.62	Insider Trans	3.83%	Shs Float	95.52M	Perf Month	-51.85%
Enterprise Value	-10.33M	PEG	-	EPS next Q	-0.12	Inst Own	48.37%	Short Float	21.14%	Perf Quarter	-51.31%
Income	-70.03M	P/S	235.11	EPS this Y	28.47%	Inst Trans	1.69%	Short Ratio	9.15	Perf Half Y	-44.70%
Sales	0.19M	P/B	0.77	EPS next Y	-7.96%	ROA	-79.17%	Short Interest	20.19M	Perf YTD	-41.82%
Book/sh	0.59	P/C	0.67	EPS next 5Y	11.51%	ROE	-105.32%	52W High	7.29 -93.75%	Perf Year	-91.64%
Cash/sh	0.68	P/FCF	-	EPS past 3/5Y	20.65% 14.76%	ROIC	-102.76%	52W Low	0.40 15.34%	Perf 3Y	-79.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-73.65% -55.14%	Gross Margin	-723.16%	Volatility	8.65% 14.63%	Perf 5Y	-90.29%
Dividend TTM	-	EV/Sales	-54.37	EPS Y/Y TTM	8.93%	Oper. Margin	-38573.68%	ATR (14)	0.06	Perf 10Y	-98.96%
Dividend Ex-Date	-	Quick Ratio	5.78	Sales Y/Y TTM	-19.15%	Profit Margin	-36857.37%	RSI (14)	37.87	Recom	2.11
Dividend Gr. 3/5Y	- -	Current Ratio	5.78	EPS Q/Q	35.99%	SMA20	-8.71%	Beta	0.58	Target Price	2.86
Payout	-	Debt/Eq	0.20	Sales Q/Q	-	SMA50	-34.92%	Rel Volume	0.78	Prev Close	0.44
Employees	58	LT Debt/Eq	0.18	Earnings	May 15 BMO	SMA200	-60.42%	Avg Volume	2.21M	Price	0.46
IPO	May 07, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.98% -	Trades		Volume	1,776,974	Change	3.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)